IT IS A STUDY TO COMPARE ENDOSCOPIC GLUE INJECTION VS ENDOSCOPIC HUMAN THROMBIN INJECTION FOR BLEEDING GASTRIC VARICES

ENDOSCOPIC GLUE INJECTION VS ENDOSCOPIC HUMAN THROMBIN INJECTION FOR BLEEDING GASTRIC VARICES â?? A RANDOMISED CONTROLLED TRIAL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026466

Enrollment

240

Registered

2020-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: HUMAN THROMBIN: Thrombin reconstituted to 100 U/ml will be injected intravariceally and Follow up endoscopy is planned on day 2,day 14,day 30,day 90 Control Intervention1: GLUE INJECT

Eligibility

Inclusion criteria

Inclusion criteria: All patients of UGI bleed with gastric varices identified as the source of bleeding at the endoscopy

Exclusion criteria

Exclusion criteria: 1.PATIENTS WHO HAD UNDERGONE PREVIOUS GLUE OR THROMBIN THERAPY WILL BE EXCLUDED 2.Obstruction to the venous drainage of the liver, pregnancy, a history of hypersensitivity to Thrombin or related compounds, and prior inclusion in the study

Design outcomes

Primary

Measure	Time frame
To look for number of episode of bleed from gastric varicesTimepoint: 3 month	—

Secondary

Measure	Time frame
NoTimepoint: no	—

Countries

India

Contacts

Public ContactGIREESH KUMAR DHAKED

SMS medical college, jaipur

drashokjhajharia@gmail.com9414236572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026